The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ARTICLENo Access

THE EARLY EFFECTS OF METRAZOL THERAPY IN CHRONIC PSYCHOTIC OVER-ACTIVITY

Published Online:https://doi.org/10.1176/ajp.95.2.327

Metrazol treatment has been carried out in a group of 42 patients (16 men, 26 women) characterized by chronic excitement over a period of 6 months to 22 years. Of these, 40 were schizophrenics and 2 chronic manics. The age range of these patients was from 19 years to 60 years. Treatment was given daily, in dosages beginning with 3 cc. of 10 per cent solution, and terminated when further improvement seemed improbable. Such procedures as previous hydration, alkalinization and camphor-in-oil injection, advocated by Meduna and others, have been found unnecessary. It was found generally, as early effects, that there was marked general improvement after treatment; there was diminution of over-activity, over-talkativeness, aggressiveness, destructiveness and incontinence; the necessity for sedation dropped tp the vanishing point; and about half the patients became capable of productive work. Open masturbation, obscenity, ready irritability, incoherency of speech and escape attempts were much diminished. Apart from the psychiatric implications of these data, the observations appear to have significance for the administrative problems involved in the custodial care of chronically disturbed patients.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.